These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22571667)

  • 1. Editorial: Protein kinase inhibitors: current strategies and future prospects.
    Caballero J
    Curr Pharm Des; 2012; 18(20):2851. PubMed ID: 22571667
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein kinase inhibitors: breakthrough medicines and the next generation.
    Sawyer TK; Wu JC; Sawyer JR; English JM
    Expert Opin Investig Drugs; 2013 Jun; 22(6):675-8. PubMed ID: 23705633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High throughput screening for protein kinase inhibitors.
    Wesche H; Xiao SH; Young SW
    Comb Chem High Throughput Screen; 2005 Mar; 8(2):181-95. PubMed ID: 15777182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Recent Advances in the Field of Kinases and Kinase Inhibitors.
    Huang Z; Lee MH
    Curr Pharm Des; 2017 Nov; 23(29):4207-4208. PubMed ID: 29231803
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in designing substrate-competitive protein kinase inhibitors.
    Han KC; Kim SY; Yang EG
    Curr Pharm Des; 2012; 18(20):2875-82. PubMed ID: 22571656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinase inhibitor conjugates.
    Harmsen S; Kok RJ
    Curr Pharm Des; 2012; 18(20):2891-900. PubMed ID: 22571658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting kinase signaling pathways with constrained peptide scaffolds.
    Hanold LE; Fulton MD; Kennedy EJ
    Pharmacol Ther; 2017 May; 173():159-170. PubMed ID: 28185915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors.
    Akritopoulou-Zanze I; Hajduk PJ
    Drug Discov Today; 2009 Mar; 14(5-6):291-7. PubMed ID: 19121409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-kinase targets of protein kinase inhibitors.
    Munoz L
    Nat Rev Drug Discov; 2017 Jun; 16(6):424-440. PubMed ID: 28280261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SnapShot: Kinase Inhibitors I.
    Wang J; Gray NS
    Mol Cell; 2015 May; 58(4):708.e1. PubMed ID: 26000854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SnapShot: Kinase Inhibitors II.
    Wang J; Gray NS
    Mol Cell; 2015 May; 58(4):710.e1. PubMed ID: 26000855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in design of biochemical assays for the identification of small molecules to target multiple conformations of protein kinases.
    Chène P
    Drug Discov Today; 2008 Jun; 13(11-12):522-9. PubMed ID: 18549979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of protein kinases.
    Shugar D; Fabbro D
    Biochim Biophys Acta; 2013 Jul; 1834(7):1269-70. PubMed ID: 23764324
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel indole alpha-methylene-gamma-lactones as potent inhibitors for AKT-mTOR signaling pathway kinases.
    Ding H; Zhang C; Wu X; Yang C; Zhang X; Ding J; Xie Y
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4799-802. PubMed ID: 16143526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-component signal transduction as potential drug targets in pathogenic bacteria.
    Gotoh Y; Eguchi Y; Watanabe T; Okamoto S; Doi A; Utsumi R
    Curr Opin Microbiol; 2010 Apr; 13(2):232-9. PubMed ID: 20138000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
    Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inhibitors of checkpoint kinase 1.
    Arrington KL; Dudkin VY
    ChemMedChem; 2007 Nov; 2(11):1571-85. PubMed ID: 17854022
    [No Abstract]   [Full Text] [Related]  

  • 18. Checkpoint kinase inhibitors: a review of the patent literature.
    Janetka JW; Ashwell S
    Expert Opin Ther Pat; 2009 Feb; 19(2):165-97. PubMed ID: 19441917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures and inhibitors of proteins involved in IL-2 release and T cell signaling.
    Brown K; Cheetham GM
    Vitam Horm; 2006; 74():31-59. PubMed ID: 17027510
    [No Abstract]   [Full Text] [Related]  

  • 20. New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors.
    Lamba V; Ghosh I
    Curr Pharm Des; 2012; 18(20):2936-45. PubMed ID: 22571662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.